Hemispherian AS is rated 3 out of 5 in the category biotechnology. Read and write reviews about Hemispherian AS. Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Our mission is to development a new drug to treat Glioblastoma Multiforme. We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients.
Address
Gaustadalleen 23a
Company size
1-10 employees